Health Care·Life Sciences Tools & Services·$5.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.35 | N/A | +10.76% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.35 | N/A | +10.76% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management expressed confidence in their ability to navigate current market challenges. They emphasized their commitment to delivering value despite external pressures.
Management highlighted strong demand in key markets.
They noted ongoing challenges in supply chain but remain focused on growth.
Avantor's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. The stock rose by 3.71%, likely driven by investor confidence in the company's performance amid ongoing market challenges. However, the lack of revenue data and guidance leaves some uncertainty about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
KIMBERLY CLARK CORP
Oct 25, 2021